261 related articles for article (PubMed ID: 26461523)
41. First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study.
Correa PJ; Venegas P; Palmeiro Y; Albers D; Rice G; Roa J; Cortez J; Monckeberg M; Schepeler M; Osorio E; Illanes SE
J Perinat Med; 2019 Feb; 47(2):161-168. PubMed ID: 30205647
[TBL] [Abstract][Full Text] [Related]
42. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
43. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
44. Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived Pregnancies.
Coussa A; Hasan HA; Barber TM
Endocr Pract; 2021 Jun; 27(6):579-585. PubMed ID: 34120700
[TBL] [Abstract][Full Text] [Related]
45. [Heterogeneity of insulin resistance level in gestational diabetes mellitus. Therapeutic implications].
Sokup A; Swiatkowski M; Dobrzyński W; Szymański W
Ginekol Pol; 2007 Jul; 78(7):527-31. PubMed ID: 17915408
[TBL] [Abstract][Full Text] [Related]
46. Elevated Circulating Levels of Carnal ENST00000550337.1 Are Associated with Polycystic Ovary Syndrome in Chinese Women.
Qi Y; Yin Q; Gu J; Liu Y; Sun Q; Cao Y; Yan X; Yuan Y; Wu J
Gynecol Obstet Invest; 2021; 86(1-2):155-161. PubMed ID: 33601399
[TBL] [Abstract][Full Text] [Related]
47. Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome.
Li G; Fan L; Zhang L; Zhang W; Huang X
J Perinat Med; 2010 Mar; 38(2):141-6. PubMed ID: 20146658
[TBL] [Abstract][Full Text] [Related]
48. Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Brennan K; Huang A; Azziz R
Fertil Steril; 2009 May; 91(5):1848-52. PubMed ID: 18439591
[TBL] [Abstract][Full Text] [Related]
49. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
Wang D; Zhu W; Li J; An C; Wang Z
PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
[TBL] [Abstract][Full Text] [Related]
50. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
51. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
53. The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.
Eid J; Kechichian T; Benavides E; Thibodeaux L; Salazar AE; Saade GR; Saad AF
Am J Perinatol; 2022 Apr; 39(5):513-518. PubMed ID: 32894869
[TBL] [Abstract][Full Text] [Related]
54. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
55. HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy.
Song S; Zhang Y; Qiao X; Duo Y; Xu J; Peng Z; Zhang J; Chen Y; Nie X; Sun Q; Yang X; Lu Z; Liu S; Zhao T; Yuan T; Fu Y; Dong Y; Zhao W; Sun W; Wang A
Int J Gynaecol Obstet; 2022 Jun; 157(3):694-701. PubMed ID: 34449903
[TBL] [Abstract][Full Text] [Related]
56. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
57. Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients.
Silva MI; Lemos CC; Torres MR; Bregman R
Nutrition; 2014 Mar; 30(3):279-85. PubMed ID: 24332526
[TBL] [Abstract][Full Text] [Related]
58. Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus.
Tawfeek MA; Alfadhli EM; Alayoubi AM; El-Beshbishy HA; Habib FA
BMC Womens Health; 2017 Mar; 17(1):18. PubMed ID: 28279160
[TBL] [Abstract][Full Text] [Related]
59. Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications.
Caglar GS; Ozdemir ED; Cengiz SD; Demirtaş S
J Obstet Gynaecol Res; 2012 Nov; 38(11):1286-93. PubMed ID: 22612716
[TBL] [Abstract][Full Text] [Related]
60. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
